Bio-Techne
$72.40Change from previous close: 0.00%
At a glance
- Revenue growth
- −0.38%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +147.77%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 15.0%
- FY to Jun 2025: 6.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 |
|---|---|---|---|---|---|
| Total revenue | 1,215 | 1,220 | 1,159 | 1,137 | — |
| Cost of revenue | 416 | 429 | 389 | 367 | — |
| Gross profit | 799 | 790 | 770 | 770 | — |
| Selling, general and administrative | 407 | 415 | 393 | 352 | — |
| Research and development | 94.8 | 99.5 | 96.7 | 92.5 | — |
| Operating income | 273 | 243 | 246 | 291 | — |
| EBIT | 250 | 107 | 201 | 350 | — |
| EBITDA | 348 | 217 | 313 | 457 | — |
| Interest expense | 9.6 | 8.5 | 15.7 | 11.2 | — |
| Pre-tax income | 241 | 98.5 | 186 | 339 | — |
| Income tax | 58.8 | 25.1 | 17.6 | 53.2 | — |
| Net income | 182 | 73.4 | 168 | 285 | — |
| Net income to common shareholders | 182 | 73.4 | 168 | 285 | — |
| Basic EPS | 1.17 | 0.47 | 1.07 | 1.81 | — |
| Diluted EPS | 1.16 | 0.46 | 1.05 | 1.76 | — |
| Average shares (basic) | 156 | 158 | 158 | 157 | — |
| Average shares (diluted) | 157 | 160 | 161 | 162 | — |